AmeriCare Home Health has been acquired by Brooks Rehabilitation
The private shareholders of AmeriCare Home Health (AmeriCare) have sold the company to Brooks Rehabilitation. Financial details have not been disclosed.
AmeriCare is a leading provider of home healthcare services including skilled nursing, physical therapy, occupational therapy, speech therapy, social work, home health aide, and private duty. The company is headquartered in Jacksonville, Florida, and operates 10 satellite office locations serving 23 counties in northeast and central Florida.
Brooks Rehabilitation is a recognized leader in providing a system of world class rehabilitation services. It operates an inpatient hospital providing rehabilitation and medical care for people requiring intensive inpatient therapy, 26 outpatient clinics, as well as Brooks Home Care which serves northeast Florida.
Oaklins' team in Jacksonville acted as financial advisor and intermediary to the seller in this transaction.


Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more